HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Health Catalyst, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.71−0.02 (-0.87%)
Close on Oct 19, 2026
- Market cap
- $126.47M
- P/E (TTM)
- –
- Dividend yield
- –
Health Catalyst, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology | $48.80M | $49.47M | $51.87M | $52.05M | $52.88M | $51.48M | $51.60M | $48.65M | $47.64M | $46.97M | $47.10M | $45.97M | 69.2% | -7.7% |
| Accumulated Impairment Losses | $21.69M | $21.29M | $22.81M | $24.27M | $27.85M | $27.93M | $28.01M | $27.70M | $28.27M | $27.76M | $27.98M | $27.80M | 30.8% | -22.1% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology | $48.80M | $49.47M | $51.87M | $52.05M | $52.88M | $51.48M | $51.60M | $48.65M | $47.64M | $46.97M | $47.10M | $45.97M | 69.2% | -7.7% |
| Recurring technology | $48.80M | $49.47M | $51.87M | $52.05M | $52.88M | $51.48M | $51.60M | $48.65M | $47.64M | $46.97M | $47.10M | $45.97M | 69.2% | -7.7% |
| Accumulated Impairment Losses | $21.69M | $21.29M | $22.81M | $24.27M | $27.85M | $27.93M | $28.01M | $27.70M | $28.27M | $27.76M | $27.98M | $27.80M | 30.8% | -22.1% |
| One-time technology (i.e., perpetual license) | – | – | – | – | – | – | – | $0 | $0 | $0 | – | $0 | – | – |
By region
From the segment and revenue-disaggregation notes of Health Catalyst's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.